K. Krogsgaard

发表

HTLV-I and -II in intravenous drug users from Sweden and Denmark.

J. Blomberg, B. Hansson, E. Nordenfelt, 1994, Scandinavian journal of infectious diseases.

Ribavirin with or without alpha interferon for chronic hepatitis C.

L. Gluud, C. Gluud, L. Kjaergard, 2002, The Cochrane database of systematic reviews.

Variables predicting elevated portal pressure in alcoholic liver disease. Results of a multivariate analysis.

E. Christensen, J. Henriksen, C. Gluud, 1987, Scandinavian journal of gastroenterology.

Correlation between liver morphology and haemodynamics in alcoholic liver disease.

C. Gluud, P. Christoffersen, K. Krogsgaard, 2008, Liver.

Relationships between liver histologic lesions and portal hypertension in patients with alcoholic cirrhosis

Y. Israel, C. Degott, R. Britton, 1985, Hepatology.

Correlation Between Liver Morphology and Portal Pressure in Alcoholic Liver Disease

J. Henriksen, C. Gluud, P. Christoffersen, 1984, Hepatology.

Hepatitis B virus DNA in serum. Applied molecular biology in the evaluation of hepatitis B infection.

K. Krogsgaard, Kim Krogsgaard, 2008, Liver.

Hepatitis B virus DNA in hepatitis B surface antigen-positive blood donors: relation to the hepatitis B e system and outcome in recipients.

J. Nielsen, J. Aldershvile, P. Kryger, 1986, The Journal of infectious diseases.

Hepatitis B virus DNA in serum from patients with acute hepatitis B

C. Bréchot, J. Aldershvile, P. Kryger, 1985, Hepatology.

WITHDRAWN: Ribavirin with or without alpha interferon for chronic hepatitis C.

L. Gluud, C. Gluud, K. Krogsgaard, 2007, The Cochrane database of systematic reviews.

Natural history and etiology of liver disease in patients with previous community-acquired acute non-A, non-B hepatitis. A follow-up study of 178 Danish patients consecutively enrolled in The Copenhagen Hepatitis Acuta Programme in the period 1969-1987.

H. Krarup, M. Franzmann, K. Krogsgaard, 1999, Journal of hepatology.

Sequential combination of glucocorticosteroids and alfa interferon versus alfa interferon alone for HBeAg-positive chronic hepatitis B.

C. Gluud, T. Poynard, P. Mathurin, 2005, The Cochrane database of systematic reviews.

Glucocorticosteroids for viral hepatitis C.

J. Brok, C. Gluud, K. Krogsgaard, 2001, The Cochrane database of systematic reviews.

Interferon alfa with or without ribavirin for chronic hepatitis C: systematic review of randomised trials

L. Kjaergard, K. Krogsgaard, C. Gluud, 2001, BMJ : British Medical Journal.

Chlamydia pneumoniae antibodies and endothelial function as assessed by flow-mediated dilation in patients with chest pain with and without ischemic heart disease.

G. Jensen, K. Krogsgaard, B. Diness, 2003, The American journal of cardiology.

No effect of antiviral (valacyclovir) treatment in fibromyalgia: a double blind, randomized study.

H. Bliddal, E. Bartels, B. Danneskiold-Samsøe, 2004, The Journal of rheumatology.

The long-term effect of treatment with interferon-alpha 2a in chronic hepatitis B. The Long-Term Follow-up Investigator Group. The European Study Group on Viral Hepatitis (EUROHEP). Executive Team on Anti-Viral Treatment.

K. Krogsgaard, 1998, Journal of viral hepatitis.

The long‐term effect of treatment with interferon‐α2a in chronic hepatitis B

K. Krogsgaard, 1998 .

Sexual transmission of hepatitis C virus: cohort study (1981-9) among European homosexual men.

R. Biggar, M. Melbye, P. Ebbesen, 1990, BMJ.

A prevalence study of HIV antibodies in rural Kenya.

K. Krogsgaard, B. Lindhardt, H. Petersen, 1987, Scandinavian journal of infectious diseases.

High Prevalence of Hepatitis C Virus (HCV) RNA in Dialysis Patients: Failure of Commercially Available Antibody Tests to Identify a Significant Number of Patients with HCV Infection

R. Purcell, J. Bukh, K. Krogsgaard, 1993 .

High incidence of hepatitis B infection and evolution of chronic hepatitis B infection in patients with advanced HIV infection.

J. Nielsen, C. Pedersen, K. Krogsgaard, 1991, Journal of acquired immune deficiency syndromes.

Mapping international impact of Danish neuroscience from 2004 to 2015 using tailored scientometric methodology

J. P. Andersen, J. Schneider, K. Krogsgaard, 2018, The European journal of neuroscience.

Hepatitis C in dialysis patients: relationship to blood transfusions, dialysis and liver disease.

K. Krogsgaard, P. Wantzin, S. Ladefoged, 1993, Kidney international.

Incidence and clinical presentation of groin injuries in sub-elite male soccer

P. Hölmich, C. Gluud, K. Thorborg, 2013, British Journal of Sports Medicine.

Independent effects of liver disease and chronic alcoholism on thyroid function and size: the possibility of a toxic effect of alcohol on the thyroid gland.

L. Hegedüs, J. Kastrup, J. Aldershvile, 1988, Metabolism: clinical and experimental.

The effects of the CXCR2 antagonist, MK-7123, on bone marrow functions in healthy subjects.

L. Hanson, D. Dale, S. Huyck, 2015, Cytokine.

Voiding problems in patients with HIV infection and AIDS.

V. Kristiansen, K. Krogsgaard, H. Colstrup, 1995, Scandinavian journal of urology and nephrology.

Virological response to interferon therapy of chronic hepatitis B as measured by a highly sensitive assay

C. Hannoun, M. Lindh, K. Krogsgaard, 2001, Journal of viral hepatitis.

Randomized controlled trial of Tesomet for weight loss in hypothalamic obesity

A. Astrup, S. Madsbad, F. Magkos, 2022, European journal of endocrinology.

The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials. European Concerted Action on Viral Hepatitis (Eurohep).

P. Andersen, H. Thomas, G. Gerken, 1994, Journal of hepatology.

δ‐Infection and suppression of hepatitis B virus replication in chronic HBsAg carriers

J. Nielsen, J. Aldershvile, P. Kryger, 1987, Hepatology.

LIVER MEMBRANE ANTIBODIES IN ALCOHOLIC LIVER DISEASE

C. Gluud, K. Krogsgaard, U. Tage‐Jensen, 1982, The Lancet.

Early appearance of antibodies to hepatitis C virus in community acquired acute non-A, non-B hepatitis is associated with progression to chronic liver disease. The Copenhagen Hepatitis Acuta Programme.

L. Mathiesen, K. Krogsgaard, J. Sonne, 1990, Scandinavian journal of infectious diseases.

[Screening of Danish blood donors for hepatitis C virus antibodies].

K. Krogsgaard, P. Wantzin, E. Dickmeiss, 1990, Ugeskrift for laeger.

Weight Loss, Improved Body Composition and Fat Distribution by Tesomet in Acquired Hypothalamic Obesity

A. Astrup, S. Madsbad, F. Magkos, 2021, Journal of the Endocrine Society.

Effectiveness of active physical training as treatment for long-standing adductor-related groin pain in athletes: randomised trial

P. Hölmich, K. Krogsgaard, A. Bjerg, 1999, The Lancet.

The influence of HTLV‐III infection on the natural history of hepatitis B virus infection in male homosexual HBsAg carriers

J. Nielsen, J. Aldershvile, C. Pedersen, 1987, Hepatology.

A randomized trial assessing the impact of written information on outpatients' knowledge about and attitude toward randomized clinical trials. The INFO trial group.

E. L. Mortensen, C. Gluud, L. Kjaergard, 2000, Controlled clinical trials.

Prevalence and prognostic significance of infection with TT virus in patients infected with human immunodeficiency virus.

H. Ullum, J. Nielsen, B. Pedersen, 2000, The Journal of infectious diseases.

Temporal relation of antigenaemia and loss of antibodies to core antigens to development of clinical disease in HIV infection.

J. Nielsen, C. Nielsen, K. Krogsgaard, 1987, British medical journal.

Characterisation of Liver membrane autoantibodies determined by indirect immunofluorescence.

K. Krogsgaard, H. Permin, U. Tage‐Jensen, 1982, Journal of clinical pathology.

Localisation of immunoglobulin on the liver cell surface in primary biliary cirrhosis

F. Hardt, J. Aldershvile, K. Krogsgaard, 1981, Journal of clinical pathology.

Relation between treatment efficacy and cumulative dose of alpha interferon in chronic hepatitis B. European Concerted Action on Viral Hepatitis (Eurohep).

P. Andersen, E. Christensen, K. Krogsgaard, 1996, Journal of hepatology.

Does corticosteroid pretreatment enhance the effect of alfa interferon treatment in chronic hepatitis B?

K. Krogsgaard, 1994, Journal of hepatology.

Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B. INTERPRED Trial Group.

P. Marcellin, D. Ouzan, A. Tran, 1996, Journal of hepatology.

Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B

K. Krogsgaard, 1994 .

Genotype Mixtures of Hepatitis B Virus in Patients Treated with Interferon

C. Hannoun, M. Lindh, K. Krogsgaard, 2002 .

Occurrence of hepatocellular carcinoma and decompensation in western european patients with cirrhosis type B

E. Christensen, G. Fattovich, G. Realdi, 1995, Hepatology.

Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis

G. Fattovich, G. Realdi, G. Giustina, 1998, American Journal of Gastroenterology.

Demonstration of an association between detection of IgG antibody reactivity towards the C‐terminal region of the preS1 protein of hepatitis B virus and the capacity to respond to interferon therapy in chronic hepatitis B

M. Lindh, K. Krogsgaard, S. Sylvan, 2008, Journal of gastroenterology and hepatology.

Other clinical studyOccurrence of hepatocellular carcinoma and decompensation in Western European patients with cirrhosis type B

E. Christensen, G. Fattovich, G. Realdi, 1995 .

PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

M. Lindh, K. Krogsgaard, S. Sylvan, 2001 .

Mutations in the X region and core promoter are rare and have little impact on response to interferon therapy for chronic hepatitis B

C. Hannoun, M. Lindh, K. Krogsgaard, 2002, Journal of medical virology.

Genotype mixtures of hepatitis B virus in patients treated with interferon.

C. Hannoun, M. Lindh, K. Krogsgaard, 2002, The Journal of infectious diseases.

TTV Viral Load As a Marker for Immune Reconstitution After Initiation of HAART in HIV-Infected Patients

O. Kirk, J. Parner, C. Madsen, 2002, HIV clinical trials.

[Occurrence of hepatitis B and C among mentally retarded].

K. Krogsgaard, P. Wantzin, N. Rosdahl, 1999, Ugeskrift for laeger.

Frequencies of hepatitis B, delta and HTLV-III virus markers in Saudi Arabia.

B. Orskov, M. Arendrup, K. Krogsgaard, 2008, Liver.

Hepatitis B virus DNA, HBeAg and delta infection during the course from acute to chronic hepatitis B virus infection

J. Nielsen, B. Hansson, J. Aldershvile, 1985, Hepatology.

Delta infection and hepatitis B virus replication in Danish patients with fulminant hepatitis B.

J. Nielsen, L. Ranek, B. Hansson, 1988, Scandinavian journal of infectious diseases.

Efficacy of Selective Antenatal Screening for Hepatitis B Among Pregnant Women in Denmark: Is Selective Screening Still an Acceptable Strategy in a Low-endemicity Country?

B. Peitersen, K. Krogsgaard, P. Wantzin, 2003, Scandinavian journal of infectious diseases.

Antibody to HIV in patients with acute hepatitis B in the period 1975-1984.

J. Nielsen, M. Arendrup, K. Krogsgaard, 1987, Scandinavian journal of infectious diseases.

Cytomegalovirus infection rate among heart transplant patients in relation to the potency of antithymocyte immunoglobulin induction therapy. Copenhagen Heart Transplant Group.

H. Arendrup, S. Boesgaard, J. Aldershvile, 1994, Transplantation proceedings.

The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo

G. Pantaleo, M. Tolstrup, R. Fromentin, 2015, PLoS pathogens.

Cytomegalovirus infection rate among heart transplant patients in relation to anti-thymocyte immunoglobulin induction therapy. Copenhagen Heart Transplant Group.

H. Arendrup, S. Boesgaard, J. Aldershvile, 1994, Scandinavian journal of infectious diseases.

Presence and Significance of TT Virus in Danish Patients on Maintenance Hemodialysis

C. Madsen, K. Krogsgaard, J. Eugen-Olsen, 2003, Scandinavian journal of urology and nephrology.

Re-boost immunizations with the peptide-based therapeutic HIV vaccine, Vacc-4x, restores geometric mean viral load set-point during treatment interruption

D. Podzamczer, B. Clotet, J. van Lunzen, 2019, PloS one.

Effects of amiodarone and thoracic epidural analgesia on atrial fibrillation after coronary artery bypass grafting.

J. Svendsen, J. Ravn, J. Aldershvile, 2004, Journal of cardiothoracic and vascular anesthesia.

HIV neutralizing antibodies: development and association with HIV related disease.

J. Nielsen, M. Arendrup, C. Pedersen, 1989, Scandinavian journal of infectious diseases.

Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trial.

M. Tolstrup, K. Krogsgaard, L. Østergaard, 2016, The lancet. HIV.

Veno-occlusive disease and peliosis of the liver after thorotrast administration

M. Jacobsen, K. Krogsgaard, A. Dejgaard, 2004, Virchows Archiv A.

[Hepatitis B in a venereological clientele in Copenhagen].

C. Petersen, K. Seier, P. Kryger, 1984, Ugeskrift for laeger.

Outpatients' knowledge about and attitude towards clinical research and randomized clinical trials. The INFO Trial Group.

E. L. Mortensen, C. Gluud, K. Krogsgaard, 1998, Danish medical bulletin.

Widespread use of condoms and low prevalence of sexually transmitted diseases in Danish non-drug addict prostitutes.

J. Nielsen, C. Gluud, C. Pedersen, 1986, British medical journal.

N‐terminal proBNP and mortality in hospitalised patients with heart failure and preserved vs. reduced systolic function: data from the prospective Copenhagen Hospital Heart Failure Study (CHHF)

J. Parner, C. Hassager, O. Nielsen, 2004, European journal of heart failure.

NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function

J. Parner, C. Hassager, S. Boesgaard, 2003, Heart.

[Screening for hepatitis B].

K. Krogsgaard, 2002, Ugeskrift for laeger.

Combined eff ect of Vacc-4 x , recombinant human granulocyte macrophage colony-stimulating factor vaccination , and romidepsin on the HIV-1 reservoir ( REDUC ) : a single-arm , phase 1 B / 2 A trial

K. Krogsgaard, L. Østergaard, T. Rasmussen, 2016 .

High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: failure of commercially available antibody tests to identify a significant number of patients with HCV infection. Copenhagen Dialysis HCV Study Group.

R. Purcell, J. Bukh, R. Miller, 1993, The Journal of infectious diseases.

Exercise program for prevention of groin pain in football players: a cluster‐randomized trial

P. Hölmich, C. Gluud, K. Krogsgaard, 2010, Scandinavian journal of medicine & science in sports.

Would you trust a surrogate respondent?

C. Gluud, K. Krogsgaard, 1997, The Lancet.

Chronic evolution of acute hepatitis B: the significance of simultaneous infections with hepatitis C and D. Copenhagen Hepatitis Acuta Programme.

L. Mathiesen, K. Krogsgaard, P. Wantzin, 1991, Scandinavian journal of gastroenterology.

Ribavirin with or without alpha interferon versus no intervention, placebo or alpha interferon for chronic hepatitis C.

C. Gluud, L. Kjaergard, K. Krogsgaard, 2002, Cochrane Database of Systematic Reviews.

Negative HCV-RNA 2 weeks after initiation of treatment predicts sustained virological response to pegylated interferon alfa-2a and ribavirin in patients with chronic hepatitis C

J. Bukh, P. Madsen, H. Krarup, 2012, Scandinavian journal of gastroenterology.

A systematic review on interferon-alpha with or without ribavirin for interferon naive, non-responders, and relapsers with chronic hepatitis C

C. Gluud, L. Kjaergard, K. Krogsgaard, 2001 .

Sequential Vacc-4x and romidepsin during combination antiretroviral therapy (cART): Immune responses to Vacc-4x regions on p24 and changes in HIV reservoirs.

G. Pantaleo, M. Ökvist, M. Tolstrup, 2017, The Journal of infection.

[Late appearance of human immunodeficiency virus infection among Danish intravenous drug addicts].

K. Krogsgaard, J. Sindrup, A. Worm, 1987, Ugeskrift for laeger.

Reactivation of viral replication in anti-HBe positive chronic HBsAg carriers.

J. Nielsen, H. Dalbøge, B. Hansson, 2008, Liver.